T 1322/17 (Ibandronate/ATNAHS) of 19.03.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T132217.20190319
- Date of decision
- 19 March 2019
- Case number
- T 1322/17
- Petition for review of
- -
- Application number
- 07014362.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Bisphosphonic acids for the treatment and prevention of osteoporosis
- Applicant name
- Atnahs Pharma UK Limited
- Opponent name
- Synthon BV
Avansor Pharma Oy
G. L. Pharma GmbH
Glenmark Pharmaceuticals s.r.o.
Stada-Arzneimittel Aktiengesellschaft
Laboratorios Liconsa, S.A.
Agrobiogen GmbH Biotechnologie
Actavis Group PTC EHF
Generica Ilac Sanayi ve Ticaret A.S.
Hexal AG
Gedeon Richter Plc.
ALIUD PHARMA GmbH / STADA Arzneimittel GmbH - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Novelty - (yes)
Inventive step - (no)
Inventive step - all requests - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.